Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Nederlof

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Cytometry|January 1, 1989
Three-color fluorescence in situ hybridization for the simultaneous detection of multiple nucleic acid sequencesP M Nederlof, D Robinson, R Abuknesha, et al.
Cytometry|January 1, 1992
Quantification of fluorescence in situ hybridization signals by image cytometryP M Nederlof, S van der Flier, N P Verwoerd, et al.
British Journal of Cancer|December 8, 2005
A multiplex PCR predictor for aCGH success of FFPE samplesE H van Beers, S A Joosse, M J Ligtenberg, et al.
Cytometry|January 1, 1990
Multiple fluorescence in situ hybridizationP M Nederlof, S van der Flier, J Wiegant, et al.
Cancer Genetics and Cytogenetics|October 1, 1989
Detection of chromosome aberrations in interphase tumor nuclei by nonradioactive in situ hybridizationP M Nederlof, S van der Flier, A K Raap, et al.
Histopathology|November 29, 2007
Goblet cell carcinoid of the appendix: a specific type of carcinomaS van Eeden, G J A Offerhaus, A A M Hart, et al.
Cytogenetics and Cell Genetics|January 1, 1990
Human gametes and zygotes studied by nonradioactive in situ hybridizationM H Pieters, J P Geraedts, H Meyer, et al.
British Journal of Cancer|April 6, 2013
Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriersE H Lips, L Mulder, A Oonk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2010
Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapyE H Lips, L Mulder, J Hannemann, et al.
Breast Cancer Research and Treatment|April 8, 2011
Neoadjuvant chemotherapy in ER+ HER2- breast cancer: response prediction based on immunohistochemical and molecular characteristicsE H Lips, L Mulder, J J de Ronde, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Cytometry|January 1, 1989
Three-color fluorescence in situ hybridization for the simultaneous detection of multiple nucleic acid sequencesP M Nederlof, D Robinson, R Abuknesha, et al.
Cytometry|January 1, 1992
Quantification of fluorescence in situ hybridization signals by image cytometryP M Nederlof, S van der Flier, N P Verwoerd, et al.
British Journal of Cancer|December 8, 2005
A multiplex PCR predictor for aCGH success of FFPE samplesE H van Beers, S A Joosse, M J Ligtenberg, et al.
Cytometry|January 1, 1990
Multiple fluorescence in situ hybridizationP M Nederlof, S van der Flier, J Wiegant, et al.
Cancer Genetics and Cytogenetics|October 1, 1989
Detection of chromosome aberrations in interphase tumor nuclei by nonradioactive in situ hybridizationP M Nederlof, S van der Flier, A K Raap, et al.
Histopathology|November 29, 2007
Goblet cell carcinoid of the appendix: a specific type of carcinomaS van Eeden, G J A Offerhaus, A A M Hart, et al.
Cytogenetics and Cell Genetics|January 1, 1990
Human gametes and zygotes studied by nonradioactive in situ hybridizationM H Pieters, J P Geraedts, H Meyer, et al.
British Journal of Cancer|April 6, 2013
Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriersE H Lips, L Mulder, A Oonk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2010
Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapyE H Lips, L Mulder, J Hannemann, et al.
Breast Cancer Research and Treatment|April 8, 2011
Neoadjuvant chemotherapy in ER+ HER2- breast cancer: response prediction based on immunohistochemical and molecular characteristicsE H Lips, L Mulder, J J de Ronde, et al.
Pageof 3